PresseBox
Pressemitteilung BoxID: 768915 (BIOTRONIK)
  • BIOTRONIK
  • Woermannkehre 1
  • 12359 Berlin
  • http://www.biotronik.com
  • Ansprechpartner
  • Manuela Schildwächter
  • +49 (30) 689051414

BIOTRONIK and Heartbeat International (HBI) Foundation Conclude Milestone Year by Opening Heart Center in the Dominican Republic

Partners in saving lives since 2010, non-profit humanitarian organization HBI and leading cardiovascular technology manufacturer BIOTRONIK, celebrate landmark year-on track to save 500 lives by year-end

(PresseBox) (Berlin, Germany / Tampa, US, ) The Heartbeat International (HBI) Foundation and BIOTRONIK announced today the opening of a new Heart Center in the Dominican capital of Santo Domingo. Volunteer physicians at the Heart Center will implant donated pacemakers and defibrillators for patients who normally would not be able to afford the cost of these lifesaving devices.

On top of providing the cardiac devices the Santo Domingo Heart Center needs, BIOTRONIK will cover the initial costs of setting up the Center, through a Christmas donation to which the company’s Berlin-based employees also contributed.

The Dominican Center’s opening comes alongside news that HBI is on track to save 500 lives by the end of 2015, with the help of both its local Heart Center volunteers and devices donated by BIOTRONIK. More than a third of this total comes from a new record set by HBI’s Heart Center in St. Augustine, Trinidad and Tobago, which recently marked its 200th implantation so far this year, exceeding the 173 lifesaving implantations performed there in 2014.

“With approximately 500 lives saved in 2015, this year was one of the most successful we’ve had since we were founded in 1984,” said Michael Maniscalco, Chief Compliance Officer of Heartbeat International. “And with the dedicated work of our local Heart Center volunteers and BIOTRONIK’s continued support, we’re looking forward to helping many more patients in 2016 and beyond.”

HBI’s Dominican Republic Heart Center is the first to be set up with the company’s financial assistance, as well as product donations. “We embrace our social responsibility to help ensure that people with severe cardiac conditions have access to the lifesaving therapy they need,” commented Manuel Ortega, Senior Vice President, BIOTRONIK. “As our support to the Santo Domingo Center demonstrates, that commitment is something our employees hold close to their hearts, and we’re looking forward to continuing our collaboration with HBI for 2016 to be another successful year in terms of lives we can save together.”

The oldest recipient of an HBI device in 2015 is 99-year old Dominga Padua from the Philippines. The youngest HBI patient in 2015 is 11-month old baby Dilip Kausalya of Namakal, India. Since 2010, BIOTRONIK has donated more than 5,600 devices to HBI.

About HBI

Heartbeat International (HBI) was founded in 1984 by Dr. Henry McIntosh from the US and Dr. Federico Alfaro from Guatemala. Over the past 31 years, HBI has grown into a world-class charitable foundation, saving 14,000 lives around the world, through its network of Heart Centers across the globe. HBI accomplishes this by providing pacemakers, implantable cardioverter defibrillators and cardiac resynchronization devices, along with all professional and medical services by doctors and hospitals, at no cost to the patient. Of the 14,000 lives HBI has saved since 1984, over 10,000 were in Latin America and the Western Hemisphere.

Website Promotion

BIOTRONIK

One of the world's leading manufacturers of cardio- and endovascular medical devices, BIOTRONIK is headquartered in Berlin, Germany, and represented in over 100 countries. Several million patients have received BIOTRONIK implants designed to save and improve the quality of their lives, or have been treated with BIOTRONIK coronary and peripheral vascular intervention products. Since its development of the first German pacemaker in 1963, BIOTRONIK has engineered many innovations, including BIOTRONIK Home Monitoring®; the world's first 4 F-compatible 200 mm peripheral stent; Orsiro, the industry's first hybrid drug-eluting stent; and the world's first implantable cardioverter defibrillators and heart failure therapy devices with ProMRI® technology.

For more information, visit: www.biotronik.com and www.heartbeatsaveslives.org